Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inna Sekirov

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Molecular Microbiology|February 26, 2004
Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7Samantha Gruenheid, Inna Sekirov, Nikhil A Thomas, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 29, 2024
Characterising the molecular epidemiology of human parechovirus in young infants in the UK and CanadaSeilesh Kadambari, Heli Harvala, Dung Nguyen, et al.
Microbiology Spectrum|December 5, 2025
Serological evaluation of coronavirus IgA and IgG antibodies in a repeated cross-sectional cohort of unvaccinated and vaccinated pregnant individuals over three months following SARS-CoV-2 infectionGuadalein Tanunliong, Ana Citlali Márquez, Hind Sbihi, et al.
Nature Communications|February 9, 2022
Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variantsJames W Saville, Dhiraj Mannar, Xing Zhu, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|September 1, 2022
Compilation of 10 Years of MIRU-VNTR Data: Canadian National Tuberculosis Laboratory's ExperienceMeenu K Sharma, Debra Janella, Alisa McGurran, et al.
American Journal of Infection Control|October 21, 2020
Serological survey following SARS-COV-2 outbreaks at long-term care facilities in metro Vancouver, British Columbia: Implications for outbreak management and infection control policiesRohit Vijh, Cher Ghafari, Althea Hayden, et al.
Scientific Reports|October 20, 2023
Uptake of SARS-CoV-2 vaccination among structurally-marginalized people who use drugs in Vancouver, CanadaHudson Reddon, Brittany Barker, Sofia Bartlett, et al.
Frontiers in Immunology|January 20, 2022
Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 OutbreaksGuadalein Tanunliong, Aaron Liu, Rohit Vijh, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 12, 2022
Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, CanadaDanuta M Skowronski, Samantha E Kaweski, Michael A Irvine, et al.
Ebiomedicine|April 5, 2021
The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, CanadaAidan M Nikiforuk, Kevin S Kuchinski, David D W Twa, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Molecular Microbiology|February 26, 2004
Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7Samantha Gruenheid, Inna Sekirov, Nikhil A Thomas, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 29, 2024
Characterising the molecular epidemiology of human parechovirus in young infants in the UK and CanadaSeilesh Kadambari, Heli Harvala, Dung Nguyen, et al.
Microbiology Spectrum|December 5, 2025
Serological evaluation of coronavirus IgA and IgG antibodies in a repeated cross-sectional cohort of unvaccinated and vaccinated pregnant individuals over three months following SARS-CoV-2 infectionGuadalein Tanunliong, Ana Citlali Márquez, Hind Sbihi, et al.
Nature Communications|February 9, 2022
Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variantsJames W Saville, Dhiraj Mannar, Xing Zhu, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|September 1, 2022
Compilation of 10 Years of MIRU-VNTR Data: Canadian National Tuberculosis Laboratory's ExperienceMeenu K Sharma, Debra Janella, Alisa McGurran, et al.
American Journal of Infection Control|October 21, 2020
Serological survey following SARS-COV-2 outbreaks at long-term care facilities in metro Vancouver, British Columbia: Implications for outbreak management and infection control policiesRohit Vijh, Cher Ghafari, Althea Hayden, et al.
Scientific Reports|October 20, 2023
Uptake of SARS-CoV-2 vaccination among structurally-marginalized people who use drugs in Vancouver, CanadaHudson Reddon, Brittany Barker, Sofia Bartlett, et al.
Frontiers in Immunology|January 20, 2022
Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 OutbreaksGuadalein Tanunliong, Aaron Liu, Rohit Vijh, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 12, 2022
Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, CanadaDanuta M Skowronski, Samantha E Kaweski, Michael A Irvine, et al.
Ebiomedicine|April 5, 2021
The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, CanadaAidan M Nikiforuk, Kevin S Kuchinski, David D W Twa, et al.
Pageof 7